Cardiome Pharma Corp. (CRME) Forms $1.55 Double Bottom; 0 Analysts Are Bullish Willbros Group, Inc. (WG) Last Week

Cardiome Pharma Corp. (CRME) formed double bottom with $1.44 target or 7.00% below today’s $1.55 share price. Cardiome Pharma Corp. (CRME) has $55.09M valuation. The stock decreased 1.57% or $0.02 during the last trading session, reaching $1.55. About 177,993 shares traded or 28.79% up from the average. Cardiome Pharma Corp. (NASDAQ:CRME) has declined 11.02% since December 31, 2016 and is downtrending. It has underperformed by 27.72% the S&P500.

Among 5 analysts covering Willbros Group (NYSE:WG), 0 have Buy rating, 0 Sell and 5 Hold. Therefore 0 are positive. Willbros Group had 6 analyst reports since July 2, 2015 according to SRatingsIntel. The firm has “Hold” rating by KeyBanc Capital Markets given on Monday, September 18. The stock has “Underperformer” rating by Credit Suisse on Wednesday, August 16. The firm has “Neutral” rating by DA Davidson given on Monday, August 10. Morgan Stanley upgraded Willbros Group, Inc. (NYSE:WG) on Friday, June 24 to “Equalweight” rating. The stock of Willbros Group, Inc. (NYSE:WG) earned “Neutral” rating by UBS on Thursday, July 2. As per Friday, March 11, the company rating was maintained by Avondale. See Willbros Group, Inc. (NYSE:WG) latest ratings:

18/09/2017 Broker: KeyBanc Capital Markets Rating: Hold Maintain
16/08/2017 Broker: Credit Suisse Rating: Underperformer Old Target: $1.25 New Target: $1.35 Maintain

Investors sentiment increased to 2.24 in 2017 Q3. Its up 1.09, from 1.15 in 2017Q2. It improved, as 6 investors sold Willbros Group, Inc. shares while 15 reduced holdings. 20 funds opened positions while 27 raised stakes. 40.08 million shares or 11.23% more from 36.04 million shares in 2017Q2 were reported. Credit Suisse Ag reported 30,040 shares. D E Shaw & stated it has 454,432 shares or 0% of all its holdings. Raymond James Ser Advsr, Florida-based fund reported 13,194 shares. Sg Americas Ltd Company, New York-based fund reported 13,300 shares. Kohlberg Kravis Roberts And Com L P reported 10.13M shares. Tower Limited Co (Trc) invested in 1,231 shares. Cornerstone Capital Management Ltd Limited Liability Company holds 11,400 shares or 0% of its portfolio. Bridgeway Cap Management stated it has 445,509 shares or 0.02% of all its holdings. 638,500 were reported by Renaissance Ltd Llc. The Ohio-based Strs Ohio has invested 0% in Willbros Group, Inc. (NYSE:WG). Huntington National Bank & Trust has invested 0% in Willbros Group, Inc. (NYSE:WG). Manufacturers Life The holds 0% of its portfolio in Willbros Group, Inc. (NYSE:WG) for 460 shares. Cutter Brokerage accumulated 98,500 shares. Menta Limited Liability Co invested in 133,984 shares or 0.06% of the stock. Auxier Asset holds 11,655 shares.

The stock increased 0.71% or $0.01 during the last trading session, reaching $1.42. About 382,175 shares traded. Willbros Group, Inc. (NYSE:WG) has declined 22.01% since December 31, 2016 and is downtrending. It has underperformed by 38.71% the S&P500.

Willbros Group, Inc., through its subsidiaries, operates as a specialty energy infrastructure contractor serving gas and oil, and power industries in the United States and Canada. The company has market cap of $89.79 million. The firm operates through three divisions: Oil & Gas, Utility T&D, and Canada. It currently has negative earnings. The Oil & Gas segment offers construction, maintenance, and lifecycle extension services to the midstream markets.

Analysts await Cardiome Pharma Corp. (NASDAQ:CRME) to report earnings on March, 6. They expect $-0.19 earnings per share, down 5.56% or $0.01 from last year’s $-0.18 per share. After $-0.20 actual earnings per share reported by Cardiome Pharma Corp. for the previous quarter, Wall Street now forecasts -5.00% EPS growth.

Investors sentiment increased to 1.09 in 2017 Q3. Its up 0.26, from 0.83 in 2017Q2. It increased, as 2 investors sold Cardiome Pharma Corp. shares while 9 reduced holdings. 7 funds opened positions while 5 raised stakes. 13.54 million shares or 10.92% less from 15.20 million shares in 2017Q2 were reported. 600,625 are owned by Alphaone Investment Svcs Ltd Llc. Pnc Financial Services Group Incorporated has 51,400 shares for 0% of their portfolio. Rock Springs Mngmt Limited Partnership has invested 0.12% in Cardiome Pharma Corp. (NASDAQ:CRME). Savings Bank Of Nova Scotia Co holds 0% in Cardiome Pharma Corp. (NASDAQ:CRME) or 10 shares. Valley National Advisers owns 50 shares. Morgan Stanley holds 0% of its portfolio in Cardiome Pharma Corp. (NASDAQ:CRME) for 2,100 shares. Royal Commercial Bank Of Canada invested in 1,889 shares or 0% of the stock. 16,339 are owned by Citadel Ltd Liability. Scotia Cap accumulated 19,120 shares. 45 were reported by Fincl Bank Of America De. Wells Fargo Company Mn reported 800 shares. Putnam Invs Limited Liability Co reported 3.09M shares. Art Llc invested in 0% or 16,718 shares. Renaissance Techs Ltd Liability Com invested in 0% or 411,413 shares. Clough Cap Prns L P has 0.41% invested in Cardiome Pharma Corp. (NASDAQ:CRME) for 2.88M shares.

Among 6 analysts covering Cardiome Pharma Corp (NASDAQ:CRME), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Cardiome Pharma Corp had 15 analyst reports since August 11, 2015 according to SRatingsIntel. The rating was reinitiated by LB Securities with “Buy” on Friday, August 14. The rating was downgraded by Zacks on Tuesday, August 11 to “Buy”. As per Wednesday, June 1, the company rating was initiated by H.C. Wainwright. Mackie upgraded the stock to “Speculative Buy” rating in Friday, May 6 report. The company was downgraded on Wednesday, August 26 by Zacks. Canaccord Genuity reinitiated Cardiome Pharma Corp. (NASDAQ:CRME) on Monday, July 17 with “Buy” rating. The firm has “Buy” rating by Brean Capital given on Friday, March 11. As per Thursday, December 22, the company rating was initiated by Leerink Swann. The stock of Cardiome Pharma Corp. (NASDAQ:CRME) has “Buy” rating given on Friday, December 15 by Mackie. The stock has “Buy” rating by Canaccord Genuity on Wednesday, November 15.